Fundraising Fox

Apollo Endosurgery

Austin, US · Delaware corporation

Biotech

Founders & leadership

TN
Todd NewtonExecutive
SC
Stefanie CavanaughExecutive
RA
Rick AndersonNamed on SEC filing
JB
John BarrNamed on SEC filing
MS
Matthew S. CrawfordNamed on SEC filing
WD
William D. McClellanNamed on SEC filing
RK
R. Kent McGaughy, Jr.Named on SEC filing
DC
David C. PacittiNamed on SEC filing
BS
Bret SchwartzhoffNamed on SEC filing
CG
Christopher GostoutNamed on SEC filing
JM
John MolesphiniNamed on SEC filing
JS
Julie ShimerNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$57.5M disclosed across 3 rounds · 2014–2020

▶$25MraisedJul 2020 · 18 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Christopher J. GostoutExecutive Officer
  • John BarrDirector
  • John MolesphiniExecutive Officer
  • Todd NewtonExecutive Officer, Director
  • Bret SchwartzhoffExecutive Officer
  • Bruce RobertsonDirector
  • Stefanie CavanaughExecutive Officer
  • R. Kent McGaughy, Jr.Director
  • David C. PacittiDirector
  • William D. McClellanDirector
  • Julie ShimerDirector
  • Rick AndersonDirector
Offering amount
$25M
Amount sold
$25M
Sales commissions
$1.6M
Placement agents
Craig-Hallum Capital Group LLC
First sale
Jul 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$20MraisedAug 2019 · 18 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Rick AndersonDirector
  • John BarrDirector
  • Matthew S. CrawfordDirector
  • William D. McClellanDirector
  • R. Kent McGaughy, Jr.Director
  • David C. PacittiDirector
  • Bret SchwartzhoffExecutive Officer
  • Christopher GostoutExecutive Officer
  • John MolesphiniExecutive Officer
  • Julie ShimerDirector
  • Todd NewtonExecutive Officer, Director
  • Stefanie CavanaughExecutive Officer
  • Bruce RobertsonDirector
Offering amount
$20M
Amount sold
$20M
Sales commissions
$1.3M
Placement agents
Craig-Hallum Capital Group LLC
First sale
Aug 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$12.5MraisedOct 2014 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeffrey A. FerrellDirector
  • Daniel L. KisnerDirector
  • Gary J G AtkinsonExecutive Officer
  • Charles MathewsDirector
  • Scott R. PancoastExecutive Officer, Director
  • Donald R. SwortwoodDirector
  • Daniel H. PetreeDirector
Offering amount
$12.5M
Amount sold
$12.5M
Finders' fees
$751.7K
Placement agents
Maxim Group, LLC
First sale
Sep 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Apollo Endosurgery raised?
Apollo Endosurgery has disclosed $57.5M raised across 3 rounds.
Where is Apollo Endosurgery headquartered?
Apollo Endosurgery is headquartered in Austin, US.